UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 941

Sortiert nach

Lenalidomide enhances the protective effect of a therapeutic vaccine and reverses immune suppression in mice bearing established lymphomas

Leukemia, 2014-02, Vol.28 (2), p.329-337

2014

Volltextzugriff (PDF)

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

Annals of oncology, 2012-06, Vol.23 (6), p.1640-1645

2012

Volltextzugriff (PDF)

Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma

Annals of oncology, 2009-04, Vol.20 (4), p.709-714

2009

Volltextzugriff (PDF)

Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo

Leukemia, 2008-01, Vol.22 (1), p.179-185

2008

Volltextzugriff (PDF)

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma

Leukemia, 2014-12, Vol.28 (12), p.2376-2387

2014

Volltextzugriff (PDF)

Mediators of Innate Immunity That Target Immature, But Not Mature, Dendritic Cells Induce Antitumor Immunity When Genetically Fused with Nonimmunogenic Tumor Antigens

The Journal of immunology (1950), 2001-12, Vol.167 (11), p.6644-6653

2001

Volltextzugriff (PDF)

Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma

Clinical cancer research, 1999-08, Vol.5 (8), p.1961-1965

1999

Volltextzugriff (PDF)

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.269-277

2013

Volltextzugriff (PDF)

Induction of TLR4-dependent CD8+ T cell immunity by murine β-defensin2 fusion protein vaccines

Vaccine, 2011-04, Vol.29 (18), p.3476-3482

2011

Volltextzugriff (PDF)

Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma

Annals of oncology, 2018-03, Vol.29 (3), p.724-730

2018

Volltextzugriff (PDF)

Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma

Bone marrow transplantation (Basingstoke), 2005-08, Vol.36 (4), p.315-323

2005

Volltextzugriff (PDF)

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

Nature biotechnology, 1999-03, Vol.17 (3), p.253-258

1999

Volltextzugriff (PDF)

Vaccination with Syngeneic, Lymphoma-Derived Immunoglobulin Idiotype Combined with Granulocyte/Macrophage Colony-Stimulating Factor Primes Mice for a Protective T-Cell Response

Proceedings of the National Academy of Sciences - PNAS, 1996-10, Vol.93 (20), p.10972-10977

1996

Volltextzugriff (PDF)

Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma : Long-term results of a clinical trial

Blood, 1997-05, Vol.89 (9), p.3129-3135

1997

Volltextzugriff (PDF)

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

The Lancet (British edition), 1995-04, Vol.345 (8956), p.1016-1020

1995

Volltextzugriff (PDF)

Mammalian defensins in immunity: more than just microbicidal

Trends in immunology, 2002-06, Vol.23 (6), p.291-296

2002

Volltextzugriff (PDF)

Tumor-specific recognition of human myeloma cells by idiotype-induced CD8+ T cells

Blood, 2000-10, Vol.96 (8), p.2828-2833

2000

Volltextzugriff (PDF)

Clinical Trial Designs for the Early Clinical Development of Therapeutic Cancer Vaccines

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1848-1854

2001

Volltextzugriff (PDF)

Toll-like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2

Science (American Association for the Advancement of Science), 2002-11, Vol.298 (5595), p.1025-1029

2002

Volltextzugriff (PDF)

Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma

Leukemia, 2012-09, Vol.26 (9), p.2114-2123

2012

Volltextzugriff (PDF)

Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis

Journal of clinical oncology, 1990-06, Vol.8 (6), p.963-977

1990

Volltextzugriff (PDF)

Tumor-Specific, Cytotoxic T-Lymphocyte Response After Idiotype Vaccination for B-Cell, Non-Hodgkin's Lymphoma

Blood, 1996-07, Vol.88 (2), p.580-589

1996

Volltextzugriff (PDF)

Tumor vaccination strategies combined with autologous peripheral stem cell transplantation

Annals of oncology, 1998, Vol.9 (suppl-1), p.S41-S46

KWAK, L. W

1998

Volltextzugriff (PDF)

Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma

Leukemia, 2015-02, Vol.29 (2), p.515-515

2015

Volltextzugriff (PDF)

Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma

Nature medicine, 2005-09, Vol.11 (9), p.986-991

2005

Volltextzugriff (PDF)

1 – 25 von 941

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(813)
Mit Volltextzugriff
(884)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Lenalidomide enhances the protective effect of a therapeutic vaccine and reverses immune suppression in mice bearing established lymphomas

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma

Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo

FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma

Mediators of Innate Immunity That Target Immature, But Not Mature, Dendritic Cells Induce Antitumor Immunity When Genetically Fused with Nonimmunogenic Tumor Antigens

Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients

Induction of TLR4-dependent CD8+ T cell immunity by murine β-defensin2 fusion protein vaccines

Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma

Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

Vaccination with Syngeneic, Lymphoma-Derived Immunoglobulin Idiotype Combined with Granulocyte/Macrophage Colony-Stimulating Factor Primes Mice for a Protective T-Cell Response

Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma : Long-term results of a clinical trial

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

Mammalian defensins in immunity: more than just microbicidal

Tumor-specific recognition of human myeloma cells by idiotype-induced CD8+ T cells

Clinical Trial Designs for the Early Clinical Development of Therapeutic Cancer Vaccines

Toll-like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2

Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma

Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis

Tumor-Specific, Cytotoxic T-Lymphocyte Response After Idiotype Vaccination for B-Cell, Non-Hodgkin's Lymphoma

Tumor vaccination strategies combined with autologous peripheral stem cell transplantation

Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma

Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma

Suchergebnisse filtern